Acorah Software Products - Accounts Production 19.2.450 false true true 31 October 2024 1 November 2023 No description of principal activity true 1 November 2024 31 October 2025 31 October 2025 05953090 Mr Robert Banner Mr Jonathan Kerry (Chair) Mr John Bird (Vice chair) Mr Robert Banner Mr David Merriman (Treasurer) Mrs Aimee Winfield Mr Anthony Bates Mr Christopher Kent Mr Jehngir Akhtar Mrs Joanne Wortley Mr Scott McLaren Mr Sudhir Bhatt Mr Stuart Berry 1116935 true false false false false false Other events Direct costs Other Other fund raising activities true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 05953090 2024-10-31 05953090 2025-10-31 05953090 2024-11-01 2025-10-31 05953090 frs-core:CurrentFinancialInstruments 2025-10-31 05953090 frs-core:ComputerEquipment 2025-10-31 05953090 frs-core:ComputerEquipment 2024-11-01 2025-10-31 05953090 frs-core:ComputerEquipment 2024-10-31 05953090 frs-core:FurnitureFittings 2025-10-31 05953090 frs-core:FurnitureFittings 2024-11-01 2025-10-31 05953090 frs-core:FurnitureFittings 2024-10-31 05953090 frs-char:CharitableCompanyLimitedByGuarantee 2024-11-01 2025-10-31 05953090 frs-bus:FullAccounts 2024-11-01 2025-10-31 05953090 frs-bus:MediumEntities 2024-11-01 2025-10-31 05953090 frs-bus:Medium-sizedCompaniesRegimeForAccounts 2024-11-01 2025-10-31 05953090 frs-bus:Medium-sizedCompaniesRegimeForDirectorsReport 2024-11-01 2025-10-31 05953090 frs-char:TotalUnrestrictedFunds 2024-10-31 05953090 frs-char:TotalUnrestrictedFunds 2025-10-31 05953090 frs-char:TotalUnrestrictedFunds 2024-11-01 2025-10-31 05953090 frs-char:TotalRestrictedIncomeFunds 2024-10-31 05953090 frs-char:TotalRestrictedIncomeFunds 2025-10-31 05953090 frs-char:TotalRestrictedIncomeFunds 2024-11-01 2025-10-31 05953090 frs-char:IndependentExaminationCharity 2024-11-01 2025-10-31 05953090 frs-bus:CompanySecretary1 2024-11-01 2025-10-31 05953090 frs-countries:EnglandWales 2024-11-01 2025-10-31 05953090 frs-char:Trustee1 2024-11-01 2025-10-31 05953090 frs-char:Trustee2 2024-11-01 2025-10-31 05953090 frs-char:Trustee3 2024-11-01 2025-10-31 05953090 frs-char:Trustee4 2024-11-01 2025-10-31 05953090 frs-char:Trustee5 2024-11-01 2025-10-31 05953090 frs-char:Trustee6 2024-11-01 2025-10-31 05953090 frs-char:Trustee7 2024-11-01 2025-10-31 05953090 frs-char:Trustee8 2024-11-01 2025-10-31 05953090 frs-char:Trustee9 2024-11-01 2025-10-31 05953090 frs-char:Trustee10 2024-11-01 2025-10-31 05953090 frs-char:Trustee11 2024-11-01 2025-10-31 05953090 frs-char:Trustee12 2024-11-01 2025-10-31 05953090 frs-char:Trustee13 2024-11-01 2025-10-31 05953090 frs-char:Trustee14 2024-11-01 2025-10-31 05953090 frs-char:Trustee15 2024-11-01 2025-10-31 05953090 frs-char:Activity1 2024-11-01 2025-10-31 05953090 frs-char:TotalUnrestrictedFunds frs-char:Activity1 2024-11-01 2025-10-31 05953090 frs-char:TotalRestrictedIncomeFunds frs-char:Activity1 2024-11-01 2025-10-31 05953090 frs-char:Activity2 2024-11-01 2025-10-31 05953090 frs-char:TotalUnrestrictedFunds frs-char:Activity2 2024-11-01 2025-10-31 05953090 frs-char:TotalRestrictedIncomeFunds frs-char:Activity2 2024-11-01 2025-10-31 05953090 frs-char:Activity3 2024-11-01 2025-10-31 05953090 frs-char:TotalUnrestrictedFunds frs-char:Activity3 2024-11-01 2025-10-31 05953090 frs-char:TotalRestrictedIncomeFunds frs-char:Activity3 2024-11-01 2025-10-31 05953090 frs-char:Activity4 2024-11-01 2025-10-31 05953090 frs-char:TotalUnrestrictedFunds frs-char:Activity4 2024-11-01 2025-10-31 05953090 frs-char:TotalRestrictedIncomeFunds frs-char:Activity4 2024-11-01 2025-10-31 05953090 2023-10-31 05953090 2024-10-31 05953090 2023-11-01 2024-10-31 05953090 frs-core:CurrentFinancialInstruments 2024-10-31 05953090 frs-char:TotalUnrestrictedFunds 2023-10-31 05953090 frs-char:TotalUnrestrictedFunds 2024-10-31 05953090 frs-char:TotalUnrestrictedFunds 2023-11-01 2024-10-31 05953090 frs-char:TotalRestrictedIncomeFunds 2023-10-31 05953090 frs-char:TotalRestrictedIncomeFunds 2024-10-31 05953090 frs-char:TotalRestrictedIncomeFunds 2023-11-01 2024-10-31 05953090 frs-char:Trustee1 2023-11-01 2024-10-31 05953090 frs-char:Activity1 2023-11-01 2024-10-31 05953090 frs-char:TotalUnrestrictedFunds frs-char:Activity1 2023-11-01 2024-10-31 05953090 frs-char:TotalRestrictedIncomeFunds frs-char:Activity1 2023-11-01 2024-10-31 05953090 frs-char:Activity2 2023-11-01 2024-10-31 05953090 frs-char:TotalUnrestrictedFunds frs-char:Activity2 2023-11-01 2024-10-31 05953090 frs-char:TotalRestrictedIncomeFunds frs-char:Activity2 2023-11-01 2024-10-31 05953090 frs-char:Activity3 2023-11-01 2024-10-31 05953090 frs-char:TotalUnrestrictedFunds frs-char:Activity3 2023-11-01 2024-10-31 05953090 frs-char:TotalRestrictedIncomeFunds frs-char:Activity3 2023-11-01 2024-10-31 05953090 frs-char:Activity4 2023-11-01 2024-10-31 05953090 frs-char:TotalUnrestrictedFunds frs-char:Activity4 2023-11-01 2024-10-31 05953090 frs-char:TotalRestrictedIncomeFunds frs-char:Activity4 2023-11-01 2024-10-31
Company registration number: 05953090
Charity registration number: 1116935
Prostaid
Trustees' Report and
Financial Statements
For The Year Ended 31 October 2025
Prostaid
Contents
Contents

| Page
--- | ---
Trustees' Report | 1—7
Independent Examiner's Report | 8
Statement of Financial Activities (including Income and Expenditure Account) | 9
Comparative Statement of Financial Activities (including Income and Expenditure Account) | 10
Balance Sheet | 11—12
Notes to the Financial Statements | 13—22

Page 1
Prostaid
Company No. 05953090
Trustees' Report For The Year Ended 31 October 2025
Trustees' Report
The trustees present their report and the financial statements for the year ended 31 October 2025.
Objectives and Activities
Aims and Objectives
The Charity’s primary objectives are:
To relieve sickness, particularly prostate-related diseases, by supporting and encouraging the treatment of prostate cancer patients. This is primarily, though not exclusively, carried out with the Department of Urology, University of Leicester NHS Trust, and associated hospitals in Leicester, Leicestershire, Rutland, and Northamptonshire.
To raise public awareness of issues relating to prostate cancer.
To provide relief of suffering among men, particularly those treated for prostate cancer and related conditions, through practical support and information for patients, their families, and dependants, delivered in ways determined by the Trustees.
The Charity’s aims and activities are regularly reviewed. Trustees have developed a five-year strategy to improve organisational effectiveness and ensure long-term sustainability. This strategy was last reviewed in 2017/18, continued through 2021/22, with the next formal review planned for 2026.
Achievements and Performance
Main Achievements
Background
Prostate cancer is the most common cancer in men in the UK, accounting for 25% of all new cancer diagnoses. According to Cancer Research UK (2017–2019):

- Around 55,300 new cases are diagnosed each year (approximately 150 per day).
- Between 2021–2023, 12,200 men died from prostate cancer (about 34 per day).
- Rates have tripled in the past 40 years due to increased detection through PSA testing. Survival rates have improved significantly: in the 1970s, only 30% of men survived five years or more, compared with 78.9% surviving ten years or more today.
- However, Leicester, Leicestershire, and Rutland still experience some of the lowest five-year survival rates for aggressive prostate cancer in the UK. Local data shows that 21% of men are diagnosed with metastasised disease, spreading to bones or other areas. Currently, over 42 new cases of prostate cancer per week are diagnosed locally, compared with 18 in Northampton and 9.6 nationally(CRUK).
- Many Prostaid Trustees and members are local men with personal experience of the disease. The Charity focuses on raising local awareness, improving patient care, and supporting families.

Despite challenges from high inflation and the rising cost of living and increases in taxation the Charity’s income remains positive.
Key Achievements
Funding of Prostaid Specialist Nurses
...CONTINUED
Page 1
Page 2
Prostaid
Trustees' Report (continued)
For The Year Ended 31 October 2025
Main Achievements - continued

- University Hospitals of Leicester (UHL): Agreement to jointly fund three specialist nurses on a 50/50 basis from February 2023, for a three-year contract covering patients from diagnosis through oncology. Review due February 2026.
- Northampton General Hospital: Specialist nurse Alice Knight’s contract renewed from 20 April 2023 for a further three years on a 50/50 basis, with renewal due in April 2026.
- Former nurse Aimee Winfield, now Sister in Ward 28A, remains a Trustee and continues work on trans perineal biopsies using Charity-funded equipment, reducing patient waiting times.
- Former Specialist Nurse Jo Wortley continues as Lead Nurse at UHL, supported by Charity-funded team members Aro Fernando, Alison Leggate, and Rebecca Mills.

UHL now has the largest prostate cancer nurse cohort in the UK, a legacy of Prostaid’s pioneering support.
Professional Training

- Northampton Prostate Cancer Nurse training has been delayed due to staff shortages, but integration with UHL under the University Hospitals of Northampton from July 2024 is expected to enable full training.
- UHL and Prostaid continue to support ongoing professional development for specialist nurses.

Raising Awareness

- Prostaid organised events at workplaces, community centres, and public venues including Samworth, GE Baker Perkins, LCFC, Leicester Racecourse, Leicester Caribbean Club, Orbit Buses, and the Ukulele Orchestra.
- Planned for 2026: Arriva Awareness Buses to reach a wider county audience.
- Special focus on men of African descent, who face a 1 in 4 lifetime risk of prostate cancer. Collaborations included the Pamela Campbell Morris Health Trust and African Caribbean Health Forum.

United Against Prostate Cancer (UAPC)

- Prostaid contributed to NHS England’s East Genomic Medicine Service Alliance project, completed October 2023.
- Local pathology and histology services now allow genetic cancer biopsy testing in Leicester and Cambridge, benefiting men at higher risk, particularly those of African descent.

Patient Information and Resources

- Leaflets produced on hormone treatment, bone health, gut health, travel insurance, brachytherapy, and PSA records, distributed across hospitals and Macmillan Cancer Information Centres.
- Radiotherapy Preparation Cards and support group leaflets developed.
- Patient folders provided, including invitation letters, treatment options, buddy leaflets, PSA record cards, and newsletters.

Da Vinci Robot
...CONTINUED
Page 2
Page 3
Prostaid
Trustees' Report (continued)
For The Year Ended 31 October 2025
Main Achievements - continued

- The £2 million Da Vinci Robot appeal (2014) continues to improve prostate surgery outcomes, with over 7,000 procedures completed.
- New robot equipment is planned for Leicester General Hospital.

John van Geest Centre (JVG)

- Trustees maintain collaboration with Nottingham Trent University’s £15 million Prostate & Breast Cancer Research Centre and participate in immunotherapy trials.

Website and Digital Presence

- Website improvements include mobile optimisation and a “Get Involved” section.
- Office 365 now provides Trustees with access to Charity archives.

Friends & Forum

- Support networks and volunteer services continue to develop.
- Plans for a Prostaid Forum to incorporate support group ideas remain ongoing.

Collaborations

- Partnerships include UHL Genetics, Macmillan, LOROS, Northampton & Kettering Hospitals, Nuffield and Spire Hospitals, Prostate Cancer UK, Tackle Prostate Cancer, and University of Leicester researchers.

Social Events and Well-being

- Christmas parties, curry evenings, and the Glen Gorse Walking Club organised five healthy walks.

Support Groups

- Four support groups in Leicester, Melton, Birstall, and Northampton continue to grow.
- Collaboration with Birstall Bags (a breast cancer charity) supports a unique joint group.
- African/Caribbean group to relaunch with support from Howard Morris.
- Southern Asian support group on hold due to increased attendance in existing groups.

Brachytherapy

- HDR (High Dose Rate) and LDR (seeded) Brachytherapy will soon be available at Leicester Royal Infirmary, reducing treatment times and improving outcomes.
- Charity-supported leaflets and video content continue to educate patients.

Page 3
Page 4
Prostaid
Trustees' Report (continued)
For The Year Ended 31 October 2025
Fundraising and Finance

- Successful events included the Prostaid Golf Day, local fund raising, memorial football match, Dragon Boat Race (£15k), and the Freeze Your Bits and Bobs Off sponsored walk.

Dedicated Prostaid Prostate Cancer Centre

- Plans for 2025–26 include additional high-profile fundraising events.
- Work continues towards a specialist Prostate Centre in Leicester, with support from UHL and Trustees. Fundraising is planned to complete by Autumn 2026.
- The proposed centre, to be called ‘The Prostate Centre’, received full written support from Chief Executive Richard Mitchell of UHL.
- Leadership team: Mr Anthony Bates (UHL Urologist and Clinical Lead), Chair Jonathan Kerry, Rob Banner, and Fundraising Manager Anna Price.
- A meeting with UHL in January 2026 will finalise the location to enable our fundraising programme to complete by Autumn 2026.

Newsletter and Leaflets

- Biannual newsletter continues, supported by Birdhouse. Leaflets distributed to hospitals, GP surgeries, and public noticeboards across Leicester, Leicestershire, Rutland, Kettering, and Northampton.

Financial Review
Fundraising and Finance

- Fundraising income increased despite post-pandemic and economic challenges.
- Reserves Policy: Minimum 12 months’ operating costs retained, with additional funds earmarked for ongoing projects.
- Expected pending legacies include £70k from the Toyne legacy

Structure, Governance and Management
Governing Document

- Charity governed by Memorandum and Articles of Association.
- Incorporated: 2 October 2006; Registered Charity: 22 November 2006.
- Trustees meet 4–6 times annually.
- Legal advice confirms fundraising for the Prostate Centre can continue under existing governing documents, with a separate bank account.

Patrons
...CONTINUED
Page 4
Page 5
Prostaid
Trustees' Report (continued)
For The Year Ended 31 October 2025
Governing Document - continued

- Richard Everard DL OBE
- Alan Birchenall MBE
- Patrons provide ongoing support and promotion of Charity objectives.

Recruitment of Trustees

- Appointments in 2025: Jonathan Kerry (Chair), Jang Akhtar, Suds Bhatt.
- Resignations: Mark Dunkley (Chair, June 2025), Peter Hayes (May 2025).

Management

- One full-time employed Trustee, Robert Banner, oversees operations.
- Honorary Treasurer: Dave Merriman; Assistant Treasurer: Faye Lord (bookkeeping and social media).
- Other key roles include Buddy Coordinators, Friends Coordinator, Awareness Coordinator, Fundraising Coordinator, and support group leads, ensuring smooth operations and direct patient support.

Volunteers

- Total volunteer hours: 1,860 hours in 2024–25, supporting patient care and services.

Risk Management

- Trustees regularly assess risks and implement appropriate mitigation measures.

Reference and Administrative Details
Trustees
Mr Jonathan Kerry (Chair) (appointed 30/07/2025)
Mr John Bird (Vice chair)
Mr Robert Banner
Mr David Merriman (Treasurer)
Mrs Aimee Winfield
Mr Anthony Bates
Mr Christopher Kent
Mr Jehngir Akhtar (appointed 30/07/2025)
Mrs Joanne Wortley
Mr Scott McLaren
Mr Sudhir Bhatt (appointed 30/07/2025)
Mr Graydon Thwaite (resigned 21/01/2025)
Mr Mark Dunkley (resigned 06/06/2025)
Mr Peter Ross (resigned 02/05/2025)
Mr Stuart Berry
Page 5
Page 6
Prostaid
Trustees' Report (continued)
For The Year Ended 31 October 2025
Company Secretary
Mr Robert Banner
Charity Number
1116935
Company Number
05953090
Principal Address
17 Torrington Close
Wigston
Leicester
Leicestershire
LE18 2RY
Registered Office
17 Torrington Close
Wigston
Leicester
Leicestershire
LE18 2RY
Independent Examiner
Martyn Griffiths FCCA
Blackthorn Griffiths Limited
Chartered Certified Accountants
Valley View Wood Lane
Tugby
Leicester
LE7 9WE
Page 6
Page 7
Prostaid
Trustees' Report (continued)
For The Year Ended 31 October 2025
Statement of Trustees' Responsibilities
The trustees (who are also the directors of Prostaid for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the trustees to prepare financial statements for each financial year. Under company law the trustees must not approve the financial statement unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing the financial statements the trustees are required to:

- select suitable accounting policies and then apply them consistently;
- observe the methods and principles in the Charity SORP;
- make judgments and accounting estimates that are reasonable and prudent; and
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The trustees are responsible for keeping adequate accounting records which disclose with reasonable accuracy at anytime the financial position of the charitable company and to enable them to ensure that the accounts comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
Small Company Rules
This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
The trustees' report was approved by the board of trustees and signed on its behalf by:

Mr Robert Banner Trustee | Mr David Merriman (Treasurer) Trustee
28th January 2026

Page 7
Page 8
Prostaid
Independent Examiner's Report to the Trustees of Prostaid
For The Year Ended 31 October 2025
Independent Examiner's Report to the Trustees of Prostaid
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 October 2025.
Responsibilities and Basis of Report
As the charity trustees of the Company (and also its directors for the purposes of company law), you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (“the 2006 Act”).
Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.
Independent Examiner's Statement
Since the charity’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of ACCA, which is one of the listed bodies.
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

1. accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair view' which is not a matter considered as part of an independent examination; or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Martyn Griffiths FCCA
28th January 2026
Valley View Wood Lane
Tugby
Leicester
LE7 9WE
Page 8
Page 9
Prostaid
Statement of Financial Activities (including Income and Expenditure Account)
For The Year Ended 31 October 2025
Statement of Financial Activities (including Income and Expenditure Account)

|  |  | 2025 | 2024
--- | --- | --- | --- | ---
| Unrestricted funds | Restricted funds | Total funds | Total funds
| Notes | £ | £ | £ | £
INCOME AND ENDOWMENTS FROM:
Donations and legacies | 4 | 144,276 | - | 144,276 | 233,924
Charitable activities: |
Other fund raising activities |  | 23,763 | - | 23,763 | 17,369
Investments | 5 | 2,196 | - | 2,196 | 5,145
|  | 170,235 | - | 170,235 | 256,438
EXPENDITURE ON:
Charitable activities: | 7
Other events |  | (9,458 ) | - | (9,458 ) | (5,723 )
Direct costs |  | (156,963 ) | - | (156,963 ) | (183,005 )
Other |  | (27,332 ) | - | (27,332 ) | (24,203 )
|  | (193,753 ) | - | (193,753 ) | (212,931 )
NET (EXPENDITURE)/INCOME |  | (23,518 ) | - | (23,518 ) | 43,507
NET MOVEMENT IN FUNDS |  | (23,518 ) | - | (23,518 ) | 43,507
RECONCILIATION OF FUNDS:
Total funds brought forward |  | 312,260 | 42,369 | 354,629 | 311,122
TOTAL FUNDS CARRIED FORWARD | 14 | 288,742 | 42,369 | 331,111 | 354,629

The notes on pages 13 to 20 form part of these financial statements.
Page 9
Page 10
Prostaid
Comparative Statement of Financial Activities (including Income and Expenditure Account)
For The Year Ended 31 October 2025
Comparative Statement of Financial Activities (including Income and Expenditure Account)

|  |  | 2024
--- | --- | --- | ---
| Unrestricted funds | Restricted funds | Total funds
| Notes | £ | £ | £
INCOME AND ENDOWMENTS FROM:
Donations and legacies | 4 | 233,924 | - | 233,924
Charitable activities: |
Other fund raising activities |  | 17,369 | - | 17,369
Investments | 5 | 5,145 | - | 5,145
|  | 256,438 | - | 256,438
EXPENDITURE ON:
Charitable activities: | 7
Other events |  | (5,723 ) | - | (5,723 )
Direct costs |  | (183,005 ) | - | (183,005 )
Other |  | (24,203 ) | - | (24,203 )
|  | (212,931 ) | - | (212,931 )
NET INCOME |  | 43,507 | - | 43,507
NET MOVEMENT IN FUNDS |  | 43,507 | - | 43,507
RECONCILIATION OF FUNDS:
Total funds brought forward |  | 268,753 | 42,369 | 311,122
TOTAL FUNDS CARRIED FORWARD | 14 | 312,260 | 42,369 | 354,629

The notes on pages 13 to 20 form part of these financial statements.
Page 10
Page 11
Prostaid
Balance Sheet
As At 31 October 2025
Balance Sheet

|  |  | 2025 | 2024
--- | --- | --- | --- | ---
| Unrestricted funds | Restricted funds | Total funds | Total funds
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 11 | - | - | - | 134
|  | - | - | - | 134
CURRENT ASSETS
Debtors | 12 | 72,675 | - | 72,675 | 91,750
Cash at bank and in hand |  | 228,124 | 42,369 | 270,493 | 274,216
|  | 300,799 | 42,369 | 343,168 | 365,966
Creditors: Amounts Falling Due Within One Year | 13 | (12,057 ) | - | (12,057 ) | (11,471 )
NET CURRENT ASSETS (LIABILITIES) |  | 288,742 | 42,369 | 331,111 | 354,495
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 288,742 | 42,369 | 331,111 | 354,629
NET ASSETS |  | 288,742 | 42,369 | 331,111 | 354,629
FUNDS OF THE CHARITY
Restricted Funds |  |  |  | 42,369 | 42,369
Unrestricted Funds |  |  |  | 288,742 | 312,260
TOTAL FUNDS | 14 |  |  | 331,111 | 354,629

Page 11
Page 12
Prostaid
Balance Sheet (continued)
As At 31 October 2025
For the year ending 31 October 2025 the charitable company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Mr Robert Banner Trustee | Mr David Merriman (Treasurer) Trustee
28th January 2026

The notes on pages 13 to 20 form part of these financial statements.
Page 12
Page 13
Prostaid
Notes to the Financial Statements
For The Year Ended 31 October 2025
Notes to the Financial Statements
1. General Information
Prostaid is a company limited by guarantee, incorporated in England & Wales, registered number 05953090 and registered charity number 1116935 . The registered office is 17 Torrington Close, Wigston, Leicester, Leicestershire, LE18 2RY.
2. Statement of Compliance
The financial statements have been prepared in accordance with the Charities SORP (FRS 102) "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)", Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Accounting Policies
3.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention.
The charitable company is a Public Benefit Entity as defined by FRS 102.
3.2. Going Concern Disclosure
The trustees have not identified any material uncertainties related to events or conditions that may cast significant doubt about the charitable company's ability to continue as a going concern.
3.3. Fund Accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.
3.4. Incoming Resources
All income is recognised once the company has entitlement to the income, it is probable that all the income will be received and the amount of income receivable can be measured reliably.
Donated services or facilities are recognised when the company has control over the item, any conditions associated with the donated item have been met, the receipt of economic benefit from use by the company of the item is probable and the economic benefit can be measured reliably. In accordance with the Chanties SORP (FRS 102), the general volunteer time of the Friends is not recognised and refer to the Trustees' report for more information about their contribution.
On receipt, donated professional services and donated facilities are recognised on the basis of the value of the gift to the company which is the amount the company would have been willing to pay to obtain services or facilities of equivalent economic benefit on the open market; a corresponding amount is then recognised in expenditure in the period of receipt.
Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.
...CONTINUED
Page 13
Page 14
Prostaid
Notes to the Financial Statements (continued)
For The Year Ended 31 October 2025
3.4. Incoming Resources - continued
Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable.
3.5. Resources Expended
Expenditure is recognised once there is a legal or consecutive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settllement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of a total of direct costs and shared costs, including support costs involved in undertaking each activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset's use.
Support costs are those costs incurred directly in support of expenditure on the objects of the company and include project management carried out at Headquarters. Governance costs are those incurred in connection with administration of the company and compliance with constitution and statutory requirements.
Charitable activities and Governance costs are incurred on the company's educational operations, including support costs and costs relating to the governance of the company, apportioned to charitable activities.
3.6. Tangible Fixed Assets and Depreciation
All assets costing more than £250 are capitalised.
A review for impairment of a fixed asset is carried out if events or changes in circumstances indicate that the carrying value of any fixed asset may not be recoverable. Shortfalls between the carrying value of fixed assets and their recoverable amounts are recognised as impairments. Impairment losses are recognised in the Statement of financial activities incorporating income and expenditure account.
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Fixtures & Fittings | five years
Computer Equipment | three years

3.7. Financial Instruments
The company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instrument are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
3.8. Taxation
The charity is exempt from corporation tax on its charitable activities.
4. Income from Donations and Legacies
Page 14
Page 15
Prostaid
Notes to the Financial Statements (continued)
For The Year Ended 31 October 2025

| 2025 | 2024
--- | --- | ---
| Unrestricted | Unrestricted
| funds | funds
| £ | £
Donations and gifts:
General donations (incl Gift Aid) | 101,196 | 191,430
Legacies and funeral donations | 7,369 | 3,127
Donations in kind | 24,644 | 28,282
Dragon Boat race | 11,067 | 11,085
| 144,276 | 233,924

5. Investment Income

| 2025 | 2024
--- | --- | ---
| Unrestricted | Unrestricted
| funds | funds
| £ | £
Bank interest receivable | 2,196 | 5,145

6. Net Income/(Expenditure)
The net (expenditure)/income is stated after charging/(crediting):

| 2025 | 2024
--- | --- | ---
| £ | £
Depreciation of tangible fixed assets - owned | 134 | 192

7. Analysis of Expenditure

|  |  | 2025
--- | --- | --- | ---
| Activities undertaken directly | Support costs (see note 8 ) | Total
| £ | £ | £
Other events | 7,832 | 1,626 | 9,458
Direct costs | 111,769 | 45,194 | 156,963
Other | 27,332 | - | 27,332
| 146,933 | 46,820 | 193,753

Page 15
Page 16
Prostaid
Notes to the Financial Statements (continued)
For The Year Ended 31 October 2025

|  |  | 2024
--- | --- | --- | ---
| Activities undertaken directly | Support costs (see note 8 ) | Total
| £ | £ | £
Other events | 5,723 | - | 5,723
Direct costs | 137,624 | 45,381 | 183,005
Other | 24,203 | - | 24,203
| 167,550 | 45,381 | 212,931

8. Support Costs

|  |  | 2025
--- | --- | --- | ---
| Other events | Direct costs | Total
| £ | £ | £
Employee costs | - | 907 | 907
Premises expenses | - | 3,065 | 3,065
General administration | 1,626 | 41,088 | 42,714
Depreciation | - | 134 | 134
| 1,626 | 45,194 | 46,820

| 2024
--- | ---
| Direct costs
| £
Employee costs | 1,080
Premises expenses | 2,722
General administration | 41,387
Depreciation | 192
| 45,381

Page 16
Page 17
Prostaid
Notes to the Financial Statements (continued)
For The Year Ended 31 October 2025
9. Staff Costs
Staff costs were as follows:

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Wages and salaries | 25,514 |  | 24,203
Social security costs | 1,818 |  | -
| 27,332 |  | 24,203

No employees received employee benefits (excluding employer pension costs) for the reporting period of more than £60,000.
10. Average Number of Employees
Average number of employees during the year was: 1 (2024: 1)
1 1
11. Tangible Assets

| Fixtures & Fittings | Computer Equipment | Total
--- | --- | --- | ---
| £ | £ | £
Cost
As at 1 November 2024 | 4,835 | 14,087 | 18,922
Disposals | - | (13,763 ) | (13,763 )
As at 31 October 2025 | 4,835 | 324 | 5,159
Depreciation
As at 1 November 2024 | 4,728 | 14,060 | 18,788
Provided during the period | 107 | 27 | 134
Disposals | - | (13,763 ) | (13,763 )
As at 31 October 2025 | 4,835 | 324 | 5,159
Net Book Value
As at 31 October 2025 | - | - | -
As at 1 November 2024 | 107 | 27 | 134

12. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Donations receivable | 72,050 |  | 91,125
Other debtors | 625 |  | 625
| 72,675 |  | 91,750

Page 17
Page 18
Prostaid
Notes to the Financial Statements (continued)
For The Year Ended 31 October 2025
13. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Trade creditors | 78 |  | 292
Other creditors | 54 |  | -
Taxation and social security | 2,299 |  | 470
Accruals and deferred income | 9,626 |  | 10,709
| 12,057 |  | 11,471

14. Movement in Funds

| As at 1 November 2024 | Income | Expenditure | As at 31 October 2025
--- | --- | --- | --- | ---
| £ | £ | £ | £
Unrestricted funds
General:
General unrestricted fund | 307,938 | 170,235 | (193,753) | 284,420
Northampton | 2,370 | - | - | 2,370
Support Groups | 1,952 | - | - | 1,952
Total unrestricted funds | 312,260 | 170,235 | (193,753 ) | 288,742
Restricted funds
Brachytherapy | 3,000 | - | - | 3,000
Website videos | 250 | - | - | 250
United Against Prostate Cancer | 39,119 | - | - | 39,119
Total restricted funds | 42,369 | - | - | 42,369
Total funds | 354,629 | 170,235 | (193,753 ) | 331,111

| As at 1 November 2023 | Income | Expenditure | As at 31 October 2024
--- | --- | --- | --- | ---
| £ | £ | £ | £
Unrestricted funds
General:
General unrestricted fund | 264,431 | 256,438 | (212,931) | 307,938
Northampton | 2,370 | - | - | 2,370

...CONTINUED
Page 18
Page 19
Prostaid
Notes to the Financial Statements (continued)
For The Year Ended 31 October 2025

Support Groups | 1,952 | - | - | 1,952
Total unrestricted funds | 268,753 | 256,438 | (212,931 ) | 312,260
Restricted funds
Brachytherapy | 3,000 | - | - | 3,000
Website videos | 250 | - | - | 250
United Against Prostate Cancer | 39,119 | - | - | 39,119
Total restricted funds | 42,369 | - | - | 42,369
Total funds | 311,122 | 256,438 | (212,931 ) | 354,629

15. Transactions with Trustees
The following trustees have been paid remuneration or have received other benefits from the charity or related entity:

Name of trustee | Legal authority | Remuneration | 2025 Total
--- | --- | --- | ---
|  | £ | £
Mr Robert Banner | Governing document provision | 27,332 | 27,332

During the previous year the following trustees have been paid remuneration or have received other benefits from the charity or a related entity:

Name of trustee | Legal authority | Remuneration | 2024 Total
--- | --- | --- | ---
|  | £ | £
Mr Robert Banner | Governing document provision | 24,203 | 24,203

No trustee expenses have been incurred.
16. Related Party Disclosures
There have been no related party transactions in the reporting period that require disclosure, except for those disclosed in the Transactions with Trustees note.
Page 19
Page 20
Prostaid
Notes to the Financial Statements (continued)
For The Year Ended 31 October 2025
17. Company limited by guarantee
The company is limited by guarantee and has no share capital.
In the event of the company being wound up, the liability in respect of the guarantee is limited to £10 per member of the company.
Page 20
Page 21
Prostaid
Detailed Statement of Financial Activities (including Income and Expenditure Account)
For The Year Ended 31 October 2025
Detailed Statement of Financial Activities (including Income and Expenditure Account)

| 2025 | 2024
--- | --- | ---
| Total funds | Total funds
| £ | £
INCOME AND ENDOWMENTS FROM:
Donations and legacies
General donations (incl Gift Aid) | 101,196 | 191,430
Legacies and funeral donations | 7,369 | 3,127
Donations in kind | 24,644 | 28,282
Dragon Boat race | 11,067 | 11,085
| 144,276 | 233,924
Charitable Activities:
Other fund raising activities
Golf days | 15,945 | 11,507
Other events | 1,045 | 3,294
Christmas party | 2,635 | 1,568
UAPC | - | 1,000
Curry night | 4,138 | -
| 23,763 | 17,369
Investments
Bank interest receivable | 2,196 | 5,145
| 2,196 | 5,145
| 170,235 | 256,438
EXPENDITURE ON:
Charitable Activities:
Other events
Dragon Boat race costs | (7,832) | (5,723)
Curry night costs | (1,626) | -
| (9,458) | (5,723)
Direct costs
General fundraising costs | (13,999) | (15,080)
Nurse's salaries | (97,770) | (122,544)
Travel expenses | (907) | (1,080)
Insurance costs | (3,065) | (2,722)
Gift and services in kind | (24,644) | (28,282)
Independent examiner's fees | (3,420) | (3,095)
Accountancy fees | (1,815) | (1,857)
Professional fees | (35) | -
Bank charges | (374) | (258)

...CONTINUED
Page 21
Page 22
Prostaid
Detailed Statement of Financial Activities (including Income and Expenditure Account) (continued)
For The Year Ended 31 October 2025

Office expenses | (6,104) | (4,405)
Support group expenses | (4,696) | (2,811)
Curry night costs | - | (679)
Depreciation of fixtures and fittings | (107) | (84)
Depreciation of computer equipment | (27) | (108)
| (156,963) | (183,005)
Other
Trustees' salaries | (25,514) | (24,203)
Trustees' NI | (1,818) | -
| (27,332) | (24,203)
| (193,753) | (212,931)
NET (EXPENDITURE)/INCOME | (23,518) | 43,507
--- | --- | ---

Page 22